Validation Excellence. Delivered With the Rigor Your Patients Deserve.
CQV Associates partners with pharmaceutical, biotechnology, and medical device companies to deliver commissioning, qualification, validation, and compliance programs that protect product quality, accelerate time to market, and stand up to the most rigorous regulatory scrutiny. From first-in-class biologics to legacy pharmaceutical sites — we bring the technical depth and operational agility your programs require.
CQV Programs Delivered
500+
Validated Systems
1,200+
First-Inspection Pass Rate
98%
Years of Expertise
20+
Your Complete Validation Partner — From Equipment Qualification to Regulatory Strategy
The name CQV Associates reflects our roots in Commissioning, Qualification, and Validation. But over two decades, clients asked us to go further — and we did. Today we are a full-spectrum validation and compliance firm, delivering everything from thermal mapping studies and cleaning validation to regulatory affairs consulting, analytical method validation, and specialist staffing across every life sciences discipline.
What has never changed is our philosophy: validation exists to protect patients. Every protocol we write, every system we qualify, every document we produce is written with that purpose in mind. That commitment — not just technical competence — is what drives our 98% first-inspection pass rate and our long-term client relationships.
Our Philosophy
“Validation exists to protect patients. Every protocol we write, every system we qualify, every document we produce is written with that purpose in mind.”
Beyond CQV — Full-Spectrum Validation for Every Regulated Industry
Validation in the life sciences is not a single discipline. It encompasses the qualification of equipment, the validation of processes and methods, the compliance of computerized systems, the regulation of medical devices, the assurance of biological products, and the systematic management of quality risk across an entire organization's lifecycle.
Pharmaceutical & Biotech Validation
Comprehensive GMP validation programs for small molecule, biologic, and combination product manufacturers — aligned to FDA Process Validation Guidance (2011), EU GMP Annex 15, and ICH Q8–Q12 quality by design principles. We cover the complete pharmaceutical manufacturing lifecycle, from clinical manufacturing through commercial-scale production.
Medical Device Validation
Design validation, process validation, test method validation, and software validation (IEC 62304) for Class I, II, and III medical devices — under ISO 13485, FDA 21 CFR Part 820/QMSR, and EU MDR 2017/745 frameworks. We understand that device validation begins with user needs and ends with post-market performance evidence.
GMP Consulting & Quality Systems
Quality management system development, GMP gap assessments, inspection readiness preparation, warning letter remediation, and regulatory strategy — built on firsthand experience with FDA, EMA, MHRA, and Health Canada. When your compliance program needs expert reinforcement, we bring the perspective of practitioners who have been on both sides of the inspection process.
Validation Training Programs
Role-specific GMP and GxP training for validation engineers, quality professionals, manufacturing personnel, and regulatory teams — from foundational GMP awareness to advanced CSV, process validation, and risk management workshops. Our training is delivered by practitioners, not academics — people who have executed the protocols and managed the deviations they teach about.
Four Core Values
The principles that guide everything we do.
Lifecycle Thinking
We integrate CQV from design through decommissioning — not as discrete events, but as a connected, living program that protects your validated state continuously. Our programs are designed from the first planning meeting with the full lifecycle in view: change control integration, periodic review schedules, requalification triggers, and continued process verification programs are part of the design — not afterthoughts.
Regulatory Depth
Our team includes former FDA investigators, ISPE contributors, and regulatory strategists who understand not just what the regulations say — but how they are enforced. When we write a validation protocol or a GMP procedure, we write it knowing it may be the subject of an inspector's scrutiny. That perspective informs every sentence.
Risk Intelligence
We apply ICH Q9 Quality Risk Management principles to determine the right level of validation effort for every system — protecting quality without creating unnecessary overhead. Revalidating everything by default without analyzing actual risk does not make your operation safer. It wastes resources and creates documentation clutter. Our risk-based approach delivers compliance that is both rigorous and rational.
Talent Depth
With 5,000+ pre-vetted life sciences professionals in our network, we staff everything from single validation engineers to complete CQV program teams — deployed in days, not weeks. Candidates are assessed by our own validation practitioners, not generic recruiters. Our staffing capability is inseparable from our consulting practice — they share the same talent pool and the same quality standards.
Our 6-Step Methodology
A Methodology Refined Over 20 Years and 500+ Programs — There is no single template for a successful validation program — every facility, every product, every regulatory context is different. But there is a consistent methodology that separates programs that deliver from programs that struggle.
Scope & Risk Assessment
Define project boundaries, system inventory, GMP impact classification, and the risk-based approach that will determine the depth of validation required for each system. Every CQV program begins with a structured risk assessment — not a scope document that lists everything and qualifies nothing.
Validation Master Planning
Develop the VMP — the blueprint for all CQV activities, defining strategy, timelines, roles, acceptance criteria, documentation hierarchy, and change control integration. A VMP is not a filing exercise; it is the governing document for the entire program.
Protocol Development
Author IQ/OQ/PQ protocols, test scripts, URS documents, and traceability matrices — written by practitioners with hands-on execution experience, not just technical writers. Protocols written by people who have executed them are better protocols.
Execution & Testing
On-site protocol execution with real-time deviation management, raw data review, and daily status reporting — keeping your project on schedule and your quality system intact. We manage execution as rigorously as we manage documentation.
Summary & QA Release
Validation Summary Reports, traceability confirmation, deviation closure, and QA sign-off — producing a complete, inspection-ready documentation package. Every deliverable is reviewed with the question: would this satisfy an FDA pre-approval inspection?
Lifecycle Maintenance
Periodic review programs, requalification planning, CPV program support, and change control CQV impact assessments — maintaining your validated state over time. Validation does not end at first approval. We design programs that acknowledge this from the start.
Client Testimonials
Real outcomes from real programs.
Sarah R.
VP Quality Operations
“CQV Associates deployed a complete validation team for our greenfield sterile fill-finish facility within two weeks. Their documentation package — every protocol, every report, every traceability matrix — was reviewed by FDA during our pre-approval inspection and received zero observations. That outcome does not happen by accident.”
Michael K.
Director of Engineering
“We needed a compressed 6-month qualification campaign for a new sterile manufacturing suite, and we needed engineers who genuinely understood ISPE Baseline and ASTM E2500 — not just protocol writers. CQV Associates delivered both. The team they mobilized hit the ground running and we did not miss a single milestone.”
Alicia L.
Head of Global Compliance
“We came to CQV Associates with an FDA warning letter related to our CSV program and data integrity across 47 computerized systems. They assessed, remediated, and re-validated every one of them in nine months. When FDA returned for the re-inspection, the warning letter was lifted.”
Sarah R.
VP Quality Operations
“CQV Associates deployed a complete validation team for our greenfield sterile fill-finish facility within two weeks. Their documentation package — every protocol, every report, every traceability matrix — was reviewed by FDA during our pre-approval inspection and received zero observations. That outcome does not happen by accident.”
Michael K.
Director of Engineering
“We needed a compressed 6-month qualification campaign for a new sterile manufacturing suite, and we needed engineers who genuinely understood ISPE Baseline and ASTM E2500 — not just protocol writers. CQV Associates delivered both. The team they mobilized hit the ground running and we did not miss a single milestone.”
Alicia L.
Head of Global Compliance
“We came to CQV Associates with an FDA warning letter related to our CSV program and data integrity across 47 computerized systems. They assessed, remediated, and re-validated every one of them in nine months. When FDA returned for the re-inspection, the warning letter was lifted.”
Commissioning, Qualification & Validation — The Foundation of GMP Compliance
Our core CQV practice has delivered over 500 programs across pharmaceutical, biopharmaceutical, and medical device manufacturing environments — from 5,000 sq ft pilot plants to 500,000 sq ft commercial facilities. Every engagement is grounded in ISPE Baseline Guide Volume 5, ASTM E2500, and the applicable FDA and EMA guidance frameworks.
Phase I — Commissioning
C&Q Foundation
Systematic startup and verification of facilities, utilities, and equipment against user requirements and design specifications. Commissioning is not a regulatory activity — but doing it right is the single most effective way to accelerate qualification and eliminate IQ/OQ deficiencies before they cost you time and money. Our commissioning teams integrate from the earliest design phases, work alongside engineering and construction, and produce documentation packages that transition seamlessly into formal qualification.
Phase II — Qualification
Regulatory Evidence
Documented evidence that equipment, utilities, and automated systems are installed correctly, operate as specified, and perform consistently under real production conditions. IQ, OQ, and PQ protocols are not box-ticking exercises — they are the evidentiary foundation on which your entire manufacturing operation rests. Our qualification teams write protocols that are technically rigorous, operationally pragmatic, and designed from the first line to be defensible when an FDA or EMA inspector reviews them.
Phase III — Validation
Lifecycle Assurance
Lifecycle evidence that manufacturing processes, cleaning procedures, and analytical methods consistently produce outcomes meeting predefined specifications. Validation is the regulatory commitment that your products will be safe, efficacious, and of the quality your patients depend on. Our validation programs are built for the long term — not just to achieve initial approval, but to sustain the validated state through process changes, equipment maintenance cycles, and evolving regulatory expectations.
Ready to Build a Validation Program That Lasts?
Tell us your program scope, timeline, and regulatory context. We will tell you exactly how we can help — and what it will take to deliver it right.